UAB Researcher Granted $1 Million to Study Deadly Bacteria Passed to Babies From 25 Percent of Mothers

Released: 22-Aug-2014 10:00 AM EDT
Source Newsroom: University of Alabama at Birmingham
Contact Information

Available for logged-in reporters only

Newswise — BIRMINGHAM, Ala. – New research from the University of Alabama at Birmingham School of Optometry will study the transmission of a bacteria that up to 40 percent of healthy women carry, which becomes deadly when passed on to infants during birth.

Narayana Sthanam, Ph.D., professor of structural biology in the Department of Optometry, has been awarded a four-year, $1 million R01 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to further Group B Streptococcus research.

GBS is the leading cause of sepsis, pneumonia and meningitis in a newborn’s first week of life, according to the Centers for Disease Control and Prevention.

“Even after extensive preventive screening and treatment of expecting mothers, GBS infects a considerable percentage of neonates, as around 25 percent of mothers pass the GBS pathogen to infants during birth,” Sthanam said. “It becomes responsible for significant neonatal mortality around the world, and no vaccines are available against GBS infections.”

This new research, “Complement evasion by Group B Streptococcus,” will address how GBS escapes the mother’s complement system, which helps to clear disease-causing pathogens like GBS from the host.

“The complement system is our first line of defense against invading pathogens,” Sthanam said.

Sthanam adds that this study will also address how to use the knowledge of GBS interactions with complement proteins as an aid for a quick and reliable diagnosis of GBS infection, and for therapeutic intervention.

“The complement system is a major effector arm of innate and adaptive immunity against invading pathogens,” Sthanam said. “Upon activation, it facilitates rapid elimination of the pathogen, but sometimes becomes complicit and cooperates in its survival leading to life-threatening infections. A credible explanation of how GBS escapes from the human complement will provide the needed input for a therapeutic intervention.”

About UAB
Known for its innovative and interdisciplinary approach to education at both the graduate and undergraduate levels, the University of Alabama at Birmingham is an internationally renowned research university and academic medical center and the state of Alabama’s largest employer, with some 23,000 employees and an economic impact exceeding $5 billion annually on the state. The five pillars of UAB’s mission deliver knowledge that will change your world: the education of students, who are exposed to multidisciplinary learning and a new world of diversity; research, the creation of new knowledge; patient care, the outcome of ‘bench-to-bedside’ translational knowledge; service to the community at home and around the globe, from free clinics in local neighborhoods to the transformational experience of the arts; and the economic development of Birmingham and Alabama. Learn more at www.uab.edu.

EDITOR’S NOTE: The University of Alabama at Birmingham is a separate, independent institution from the University of Alabama, which is located in Tuscaloosa. Please use University of Alabama at Birmingham on first reference and UAB on all subsequent references.

VIDEO: www.youtube.com/uabnews TEXT: www.uab.edu/news TWEETS: www.twitter.com/uabnews


Comment/Share